INTRODUCTION {#S1}
============

Malaria is a major public health problem and according to the World Health Organization (WHO) affects more than 200 million individuals and kills over 600,000 children each year \[[@R1]\]. Parasitized red blood cells (RBC) release pathogen associated molecular patterns and danger associated molecular patterns, which lead to systemic inflammation that is largely responsible for various signs of disease as well as tissue associated pathology, in the lungs, kidney and placenta \[[@R2]\]. The acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are normally related to influenza infection \[[@R3], [@R4]\], but may also be a complication of either *Plasmodium falciparum* \[[@R5], [@R6]\] and *P. vivax* \[[@R7], [@R8]\] infections in humans \[[@R5], [@R9], [@R10]\]. Like in other severe forms of malaria, MA-ARDS/ALI seems to be related to sequestration of *Plasmodium* infected erythrocytes in the lungs \[[@R11]\].

Different studies have shown that the molecule CCR4 is a known chemokine receptor for CCL17 and CCL22 and is classically involved in the recruitment of Th2 lymphocytes that mediate lung pathology in asthma and allergic reactions \[[@R12], [@R13]\]. In addition, CCL17 and CCL22 mediates infiltration of CCR4-expressing regulatory T cells (Treg) promoting immunological escape during tumor development \[[@R14]\] as well as viral infection \[[@R15]\]. CCR4 were demonstrated to be able to recognize high concentrations of others putative ligands like CCL2, CCL3 and CCL5 chemokines \[[@R16]\]. The C57BL/6 mice infected with the NK65 strain of *P. berghei* (*PbN*) have been used as a model for MA-ARDS/ALI \[[@R17]\]. In this model, sequestration of infected erythrocytes and the presence of hemozoin are related with lung tissue damage similar to human disease \[[@R11], [@R18]\]. Likewise, biochemical alterations in the lipid composition of surfactant also contribute to lung inflammation and damage \[[@R19]\], whereas heme oxigenase-1 protects *P. berghei* ANKA (*PbA*)-infected in mice against MA-ARDS/ALI \[[@R20]\]. Others studies focusing on immunological mechanisms shows that CD8^+^ T lymphocytes and IFN-γ responses are central components in the immunologic mechanisms that mediate pathology in the lungs and other local and systemic complications as well as lethality \[[@R21], [@R22]\].

Monocytes are highly plastic cells and capable to differentiate into dentritic cells (DC) upon infectious challenge \[[@R23], [@R24]\]. In a previous study, we demonstrated that infection with *PbA* promotes the differentiation of splenic monocyte derived dendritic cells (MO-DCs), which are then recruited to the CNS and mediate cerebral malaria in a CCR5-dependent manner \[[@R25]\]. In this study, we sought to evaluate the role of MO-DCs in MA-ARDS/ALI. We found that MO-DCs are not only a main component of the inflammatory infiltrate, but play a major role in lung tissue damage observed in *PbN* infected mice. Intriguingly, we found that in this MA-ARDS/ALI model, functional CCR4 is required for promoting MO-DC recruitment and lung tissue damage mediated by Th1 immune response. Once in the lungs MO-DCs acquire the potential to produce TNF-α e iNOS, becoming Tip-DCs, which are the effector cells that mediate tissue damage and lethal MA-ARDS/ALI.

MATERIALS AND METHODS {#S2}
=====================

Ethics statement. {#S3}
-----------------

Experiments with mice were conducted according to institutional guidelines for animal ethics and approved by the institutional ethic committees from Oswaldo Cruz Foundation (Fiocruz-Minas, CEUA/LW14/15).

Mice. {#S4}
-----

C57BL/6 mice, CCR4^−/−^, CCR2^−/−^, β2-microglobulin^−/−^, IFN-γ^−/−^ and NOS2^−/−^ were bred and maintained in microisolators at Fiocruz-Minas for 4 weeks until the use. TNFR1^−/−^ mice were kindly provided by Dr. Leda Quercia from Departament of Biochemistry and immunology (Universidade Federal de Minas Gerais). Female and male mice between 6 to 10 weeks old were used in all experiments.

*Plasmodium berghei* NK65 infection. {#S5}
------------------------------------

The *Plasmodium berghei* NK65 (*PbN*) used in our experiments is originally from the Department of Parasitology at New York University and was obtained from Dr. Antoniana Krettli laboratory at Centro de Pesquisas René Rachou - Fiocruz. Briefly, *PbN* strain was maintained in Swiss mice by maximum of eight serial blood passages once-twice week, when parasitemia reached 3--4% of iRBCs. Parasites were then transferred to C57BL/6, before experimental groups were infected with *PbN*. Wild type C57BL/6 and knockout mice in the C57BL/6 genetic background were infected i.p. with 10^4^ iRBCs diluted in PBS 1X. All mice received paraminobenzoic acid 3 days before experimental challenge to improve parasite growth \[[@R26], [@R27]\].

Lung extraction and leukocytes isolation. {#S6}
-----------------------------------------

Uninfected and infected mice at different days post-infection were anesthetized, perfused with 20 ml of PBS by right ventricular puncture, lungs harvested and placed on ice. The lungs were then spliced with scissors and incubated with liberase (Sigma, St. Louis, MO) for 60 minutes at 37°C. The lungs were passed through a 100 μm nylon cell strainer to separate single cells. The resulting cell suspensions were centrifuged and the pellet was suspended in 35% Percoll solution \[[@R28]\]. After a new centrifugation at 2,500 rpm for 20 minutes, the supernatant with lung cells were discarded and pellet containing leukocytes suspended in ACK buffer to lyse RBC. The purified white blood cells were then washed and suspended in RPMI 1640 medium supplemented with penicillin, streptomycin and 5% fetal bovine serum (Gibco, ThermoFisher, Waltham, MA) and processed to be used in our experiments.

Evaluation of lung damage and histopathology. {#S7}
---------------------------------------------

The lungs were harvested after being perfused from infected and control mice. Lungs were placed on a flat device and pictures were taken for macroscopic evaluation of edema and blood presence. Added to this, the lung biopsies were fixed in 10% neutral buffered formalin (pH 7.2) for at least 78h. Samples were then dehydrated, cleared, embedded in paraffin, sectioned at 3--4μm thick and stained with hematoxylin and eosin (HE) for histopathological studies through the an optic BX53 Biological microscope equipped with Camera Qcolor5 -Ollympus. All biopsies were retained and assessed histologically. Chronic inflammatory reactions in samples were based on the presence or absence of plasma cells, macrophages (epithelioid cells and giant cells), lymphocytes, and unorganized or organized granulomas. Some parameters were evaluated such as thickening of bronchi and pleura, perivascular inflammatory infiltrate, edema and alveolar infiltrate, hemorrhage, atelectasis and pulmonary necrosis, bronchial occlusion, and a frequency of polymorphonuclear cells (neutrophils and eosinophils) in stained slides. Hematoxylin and eosin staining was also used to characterize the semi-quantitative procedure (slight to intense). The scoring system was based on previously report \[[@R17]\] with modifications, as follow: 0 = does not display, no injury (apparently histologically normal tissue); 1 = discrete and slight, when the lesion occupies less than 25% of the tissue; 2 = moderate when the lesion occupies 25 to 50% of the tissue; and 3 = intense, a severe injury with diffuse or focal inflammation around all structure of biopsy occupying more than 50% of the tissue.

The permeability were evaluated by Evans blue dye (2% in PBS, 100 μl), which was injected intraveneously and 1 hour later, the lungs were perfused and dissected. The lungs were homogenized in PBS (100 μg tissue/ml), mixed with 2 volumes formamide and incubated at 60°C for 24 hours. After centrifugation, the Evans blue concentration in the extract was determined by measurement of the absorbance at 630 nm and comparison with a standard dilution curve.

qPCR. {#S8}
-----

RNA was extracted from lungs of control and infected mice with Trizol reagent (Invitrogen), transcribed to cDNA, and primers for CCL2 (F 5-TGGCTCAGCCAGATGCAGT-3, R 5-TTGGGATCATCTTGCTGGTG-3), CCL4 (F 5-TCTTGCTCGTGGCTGCCT-3, R 5-GGGAGGGTCAGAGCCCA-3), CCL5 (F 5-CAAGTGCTCCAATCTTGCAGTC-3, R 5-TTCTCTGGGTTGGCACACAC), CCL17 (F 5-CAGGGATGCCATCGTGTTTC-3, R 5-CACCAATCTGATGGCCTTCTT-3), CCL22 (F 5-TACATCCGTCACCCTCTGCC-3, R 5-CGGTTATCAAAACAACGCCAG-3), CXCL9 (F 5-AATGCACGATGCTCCTGCA- 3, R 5-GGTCTTTGAGGGATTTGTAGTG-3) and CXCL10 (F 5- GCCGTCATTTTCTGCCTCA-3, R 5-CGTCCTTGCGAGAGGGATC-3) (Integrated DNA Technologies) used to quantify gene expression by PCR.

DNA from lungs of *PbN*-infected mice was extracted by illustra tissue & cells genomicPrep Mini spin kit (GE Healthcare). The primers of mouse endogenous gene, GAPDH (Forward: GGCAAATTCAACGGCACAGT and Reverse: AGATGGTGATGGGCTTCCC) and the *Plasmodium berghei* 18S ribosomal 18S gene (Forward: AAGCATTAAATAAAGCGAATACATCCTTA and 18S Reverse: GGAGATTGGTTTTGACGTTTATGT) were used to determine the parasite load in the lungs by relative quantification, normalized with the mouse GAPDH (ΔCT). The quantitative PCRs were carried out with the Platinum SYBR Green protocol (Invitrogen) on an Applied Biosystems 7500 real-time PCR system.

Flow cytometry. {#S9}
---------------

Isolated leukocytes from lungs of uninfected control as well as infected mice were stained with labeled monoclonal antibodies (mAbs) specific for cell surface markers or intracellular transcription factors or cytokines. mAbs for flow cytometry specific for CD11c (-Alexa-fluor 700), CD11b (-PECy7 or -APCCy7), MHCII (-PE), F4/80 (-PerCP-Cy5.5), DCsign (-APC), CD8(-APCCy7 -PECy5), CD4 (- FITC), Ly6c (-efluor-450), CD80 (-PE), CD86 (-PECy5), CD115 (-FITC), CD3 (-FITC) and CD3 (-efluor-450) were obtained from eBioscience and CD68 (-biotinylated plus streptavidin conjugated with Qdot605) was obteined from Invitrogen. The intracellular fixation and permeabilization buffer set of eBioscience was used to perform IFN-γ- APC, TNF-α-PE and NOS2-PE. To Tbet-PE, GATA-3-PE, RORγT-PE and Foxp3-PE transcription factors staining the Foxp3 staining buffer set was used (eBioscience).

Cytokine Measurements. {#S10}
----------------------

Cytokine levels were measured in the supernatant of macerated lungs homogenate from *Pb*N-infected and control mice by using the commercially available ELISA Duoset kit from Becton & Dickson (Franklin Lakes, NJ).

Statistical analysis. {#S11}
---------------------

All data were analyzed using Graphpad Prism 5.0 Software. The differences between two groups were verified using *t* test or Mann-Whitney test for parametric or nonparametric data, respectively. For analysis with more than two groups we used ANOVA or Kruskal-Wallis for parametric or nonparametric data, respectively. Differences were considered statistically significant when *p* \< 0.05.

RESULTS {#S12}
=======

CCR4 deficient mice do not develop lethal MA-ARDS/ALI. {#S13}
------------------------------------------------------

Consistent with previous studies infection with *PbN* caused MA-ARDS/ALI in C57BL/6 mice \[[@R17]\]. The results presented in [Figure 1A](#F1){ref-type="fig"} show that CCR4 deficient mice infected with *PbN* are protected from pronounced lung damage when compared to wild type (WT) mice, as indicated by macroscopic phenotype (left panel) and evans blue staining (right panel and graph). Because lung weight is augmented due to edema and cell infiltrate, we measured lungs weight in controls and *PbN* infected animals. Indeed, the lungs from infected WT mice are heavier than lungs from infected CCR4^−/−^ mice ([Figure 1B](#F1){ref-type="fig"}). In addition, lungs from *PbN*-infected mice were dissected at 9 days post-infection, sections stained with hematoxylin--eosin and evaluated as indicated in material and methods. The histopathological analysis indicates that CCR4^−/−^ mice are resistant to MA-ARDS/ALI. Hemorragy, edema, infiltrate of pleura and thickening of pleura, arterioles and alveolus were significantly higher when comparing WT and CCR4^−/−^ mice infected with *PbN* ([Figure S1](#SD1){ref-type="supplementary-material"}). In contrast, we observed that parasitaemia was similar in WT and CCR4^−/−^ mice, up to 10--12 days post-infection, before the death of WT mice ([Figure 1D](#F1){ref-type="fig"}).

Consistent with histopathology findings, CCR4^−/−^ mice were more resistant to *PbN* induced lethality than WT mice that is observed around 10 days post-infection ([Figure 1E](#F1){ref-type="fig"}). Furthermore, experiments with bone marrow transfers indicate that early lethality in *PbN*-infected mice is mediated by hematopoietic cells, since chimeric WT mice that received CCR4^−/−^ hematopoietic cells did not developed MA-ARDS/ALI ([Figure 1F](#F1){ref-type="fig"}) and the majority of CCR4^−/−^ mice that received bone marrow cells from WT donors died until 12 days post-infection ([Figure 1G](#F1){ref-type="fig"}).

CCR4 mediated tissue pathology in the lung is associated with the presence of Tbet-expressing T lymphocytes. {#S14}
------------------------------------------------------------------------------------------------------------

A previous study employing *PbN* mouse model of MA-ARDS/ALI shows that depletion of CD8^+^ T cells protects mice from lung damage and lethality \[[@R17]\]. We observed that CD8^+^ T cells from either uninfected or infected mice express CCR4, whereas CD4^+^ T lymphocyte did not. Furthermore, both activated CD4^+^ T and CD8^+^ T from infected mice expressed CXCR3 ([Figure 2A](#F2){ref-type="fig"}). The main gate strategies to study T cells were based on the expression of CD3^+^, CD4^+^ and CD8^+^ and the exclusion of F4/80 and CD19 expressing cells ([Figure S2](#SD1){ref-type="supplementary-material"}). We evaluated the migration of T lymphocytes and CCR4 deficiency did not impact on CD8^+^ T cell migration to the lungs of *Pb*N- infected mice ([Figure 2B](#F2){ref-type="fig"}). Then we performed a kinetics to verify the migration of T cells to the lungs on days 0, 3, 5, 7 and 9 post *Pb*N infection. We observed an increase in the frequency and numbers of CD8^+^ T cells beginning at day 7 post-infection ([Figure S3A and S3B](#SD1){ref-type="supplementary-material"}). Furthermore, we demonstrated that CCR4 did not interfere with T cell activation, as indicated by CD44 and CD62L expression ([Figure S3C](#SD1){ref-type="supplementary-material"}).

Next, we verified the expression of Tbet (Th1 marker), GATA-3 (Th2 marker), ROR0γt (Th17 marker) and FoxP3 (Treg marker) by CD8^+^ T and CD4^+^ T cells recruited to the lungs of CCR4^−/−^ and WT mice infected with *PbN* ([Figure 2C, 2D](#F2){ref-type="fig"} and [S4A](#SD1){ref-type="supplementary-material"}). We noticed that a high frequency of CD4^+^ T and CD8^+^ T lymphocytes in the lungs of infected mice expressed Tbet. In contrast, the frequency of CD4^+^ T cells expressing FoxP3 was decreased in the lungs of infected mice. The frequency of either RORγt- or GATA-3-expressing CD4^+^ T and CD8^+^ T were low and not altered in control and infected C57BL/6 mice. The CCR4 deficiency did not impact in the frequency of Tbet, GATA-3, RORγt or FoxP3 positive T lymphocytes in the lungs of control or infected mice. Similar analysis was performed in spleen of control of *PbN*-infected WT and CCR4^−/−^. It was observed a dominance of Tbet^+^ as well as FoxP3^+^ T cells. The lack of functional CCR4 impacted on the differentiation of Treg (FoxP3^+^), but not on Tbet^+^ Th1 or CD8^+^ T lymphocytes ([Figure S4B and S4C](#SD1){ref-type="supplementary-material"}).

Increased frequency of iNOS/TNF-α producing monocyte derived dendritic cells (Tip-DC) during MA-ARDS/ALI development. {#S15}
---------------------------------------------------------------------------------------------------------------------

Since no impairement of T cells recruitment, activation and differentiation to the Th1 phenoype was observed, we asked whether the CCR4 deficiency would interfere with the migration of myeloid cells to the lungs of *PbN*-infected mice. The experiment shows a time dependent increase in the frequence and numbers of F480^+^CD11b^+^Ly6c^+^ cells in the lungs of infected C57BL/6 mice ([Figure 3A](#F3){ref-type="fig"} and [S5A](#SD1){ref-type="supplementary-material"}). A deeper analysis of monocyte subsets show a high frequency of MO-DC markers, such as CD11c and DCsign, stimulatory molecules MHCII, CD80 and CD86, and a negative expression of the blood monocyte marker CD115, the classical dendritic cells maker CD135 and the macrophage marker CD68 ([Figure 3B](#F3){ref-type="fig"}). All these DCs markers in Ly6c+ and Ly6c- cells were evaluated to medium fluorescence intensity (MFI) as demonstrate in our results ([Figure S6A and S6B](#SD1){ref-type="supplementary-material"}). Moreover, we performed an intracellular staining and analyzed by flow cytometry and found a higher frequency of differentiated MO-DC cells expressing TNF-α and iNOS proteins compared to neutrophils and alveolar macrophages ([Figure 3C](#F3){ref-type="fig"}). These findings indicate that Tip-DC is a dominant DC subset and the main source of reactive nitrogen species in the lung tissue during MA-ARDS/ALI. The total numbers and frequency of other leucocytes in the lungs of infected mice were also evaluated, but we did not detect significant differences when compared to controls ([Figure S7A and S7B](#SD1){ref-type="supplementary-material"}).

CCR4, but not CCR2, is involved in MO-DC recruitment to the lungs during MAARDS/ALI. {#S16}
------------------------------------------------------------------------------------

Previous studies demonstrate that Tip-DCs migrate to peripheral organs in a CCR2 dependent manner \[[@R29]\]. The dependency of CCR2 for monocyte functions seems to differ in malaria models depending on infective parasite species or tissue site of pathology that are being evaluated \[[@R25], [@R30]\]. To verify possible ligands of CCR4 present in the lungs, we performed a qPCR to quantify the expression of CCL2, CCL3, CCL5, CCL17 and CCL22. While CCL5, CCL17 and CCL22 were not expressed in the lungs of *PbN* infected mice when compered to uninfected mice, we verified an increased expression of CCL2 and CCL3 by qPCR ([Figure 4A](#F4){ref-type="fig"}). Consistently, we found high levels of CCL2 protein, both in lungs and serum from *PbN*-infected mice ([Figure 4B](#F4){ref-type="fig"}). We also show by representative histogram and quantitative expression by MFI (graph) that F4/80^+^CD11b^+^ cells constitutively express both CCR2 and CCR4 ([Figure 4C](#F4){ref-type="fig"}). Because CCR2 is important for monocytes egress from bone marrow, we verified if migration of MO-DC to the lungs is CCR2 and CCR4 dependent. Surprisingly, we found that MO-DC migration to the lungs were profoundly impaired in CCR4^−/−^ mice. In contrast, the frequence of monocytes/MO-DC in the lungs of CCR2^−/−^ mice at 9 days post-infection was not affected ([Figures 4D and 4E](#F4){ref-type="fig"}). Consistently, CCR2^−/−^ mice have the same survival rate than WT mice, whereas CCR4^−/−^ was more resistant to challenge with *PbN* (Figures [1](#F1){ref-type="fig"} and [4F](#F4){ref-type="fig"}). To better understand the CCR4 role in myeloid cells, we performed a kinetic experiments in WT, CCR2^−/−^ and CCR4^−/−^ mice at 0, 5, 7 and 9 days post-infection to evaluate the frequence of monocytes derived cells and neutrophils in the lungs, spleen and blood. CCR2^−/−^ mice showed low frequence of monocytic cells in blood and spleen and a delayed recruitment to the lungs. In contrast, the frequences of monocytes in blood and spleen of *PbN* infected CCR4^−/−^ mice were similar to WT mice, but the recruitment to the lungs was severily impaired. The recruitment of neutrophils to the lungs were increased in CCR2^−/−^ mice at 5,7 and 9 days post-infection, while not affected in infected CCR4^−/−^ mice ([Figure S8A and S8B](#SD1){ref-type="supplementary-material"}).

CD8^+^ T cells- and IFN-γ-dependent differentiation of Tip-DC during MA-ARDS/ALI. {#S17}
---------------------------------------------------------------------------------

Since CD8^+^ T lymphocytes and Th1 mediated responses have been shown to play important role on MA-ARDS/ALI development in the *PbN* model, we infected IFN-γ^−/−^ and β2-microglobulin^−/−^ mice and compared the lung damage by macroscopy and lethality. We showed that hemorrhagic lesions (left panel) and lethality (right panel) are dependent of both CD8^+^ T cells and IFN-γ ([Figure 5A and 5B](#F5){ref-type="fig"}). CXCR3 is the chemokine receptor for CXCL9 and CXCL10, which are inducible by IFN-γ and key chemotactic factors for activated Th1 and CD8^+^ T lymphocytes \[[@R31]\]. Hence, we investigated the expression of CXCL9 and CXCL10 in the lungs of infected WT, IFN-γ^−/−^ and β24microglobulin^−/−^ mice. Expression of both CXCL9 and CXCL10 mRNA were decreased in the lungs of both IFN-γ^−/−^ and β2-microglobulin^−/−^ infected with *PbN* ([Figure 5C](#F5){ref-type="fig"}).

Previous studies have demonstrated that differentiation of MO-DCs is highly dependent on endogenous IFN-γ \[[@R23], [@R25], [@R32]\]. Next, we evaluated the expression of dendritic cell surface markers DCsign (CD 209) and CD11c surface on F4/80^+^CD11b^+^Ly6c^+^ cells, in order to verify if differenciation of MO-DCs in the lungs is affected either in IFN-γ^−/−^ or β2-microglobulin^−/−^ mice ([Figure 5D and 5E](#F5){ref-type="fig"}). In fact, we observed that DCsign and CD11c were not expressed by F4/80^+^CD11b^+^L6c^+^ cells in the lungs from IFN-γ^−/−^ infected with *PbN*. In contrast, deficiency of β2-microglobulin did not impact on MO-DC differenciation in the lungs of infected mice ([Figure 5D](#F5){ref-type="fig"}). We also found that high levels of IFN-γ and TNF-α are produced in the lungs of *Pb*N-infected C57BL/6 mice ([Figure 5F](#F5){ref-type="fig"}). Additionally, our analisys show that both in the lungs and spleens CD3^+^ cells represent more than 94% of IFN-γ producing cells ([Figure S9A](#SD1){ref-type="supplementary-material"}). The intracellular staining also shows that CD8^+^ T cells are the main source of IFN-γ in the lungs ([Figure 5G](#F5){ref-type="fig"}). Importantly, we found that compared to WT mice, the number of Tip-DCs in the lungs of infected β2-microglobulin^−/−^ was reduced ([Figure 5H](#F5){ref-type="fig"}). Hence, our results suggest that differentiation of MO-DC into Tip-DC requires production of IFN-γ by CD8^+^ T cells.

Requirement of NOS2 expression by Tip-DC for MA-ARDS/ALI development in *PbN* infected mice. {#S18}
--------------------------------------------------------------------------------------------

Finally, the lack of Tip-DCs expressing NOS2 resulted in protection against MA-ARDS/ALI development ([Figure 6A](#F6){ref-type="fig"}) and lethality during the early stage of *PbN* infection ([Figure 6B](#F6){ref-type="fig"}). Indeed, we found that emergence of F4/80^+^CD11b^+^Ly6c^+^ (counter plots) expressing DCsign (histogram) in the lungs of NOS2^−/−^ mice was similar to that observed in WT mice infected with *PbN* ([Figures 6C](#F6){ref-type="fig"}, **bottom right panel**). We also investigated the frequence of NOS2^+^ cells in the lungs of infected WT mice. Our results indicate that Tip-DCs are the most important NOS2 expressing cells in the lungs from *PbN* infected mice ([Figure 6D](#F6){ref-type="fig"}).

TNFα has been shown to induce NOS2 expression. Hence, TNFR1^−/−^ mice were infected with *PbN*. In contrast to NOS2^−/−^, the TNFR1^−/−^ mice were not resistent to MA- ARDS/ALI ([Figure S10A](#SD1){ref-type="supplementary-material"}). Importantly, the monocytes derived from NOS2^−/−^ produced TNF-α, in similar levels to monocytes from infected C57BL/6 mice. Likewise, the monocytes derived cells from mice deficient to TNFR1 receptor were capable to produce NOS2 similar to WT mice ([Figure S10B and S10C](#SD1){ref-type="supplementary-material"}), futher suggesting that TNFα is not involved in the pathogenesis of MA-ARDS/ALI in this model.

The results of lung damage, histopathology, parasitemia and parasite load in the lungs in different knockout lineages are summarized in [Figure S11](#SD1){ref-type="supplementary-material"}. It is noteworthy that we observe no correlation with parasitism and lung pathology, indicating that tissue inflammation is the main cause of MA-ARDS/ALI. Altogether, our results indicate that during infection with *PbN*, monocytes differentiate into MO-DC that migrate to the lungs in a CCR4-dependent manner. The MO-DCs are then activated by IFN-γ- producing CD8^+^ T cells and differentiate into Tip-DC, which are the effector cells mediating lung tissue damage during MA-ARDS/ALI through the production of reactive nitrogen species.

DISCUSSION {#S19}
==========

In this study we demonstrate that CCR4 plays a central role in mediating lung damage in MA-ARDS/ALI model, which is typically characterized by the presence of Th1 and CD8^+^ T lymphocytes and IFN-γ dependent immune response \[[@R34], [@R35]\]. Indeed, we demonstrate that the majority of infiltrating activated CD4^+^ and CD8^+^ T cells in the lungs from *Pb*N-infected mice express both CXCR3 and Tbet, which are indicative of IFN-γ producing T cells \[[@R36]\]. We also identified a group of myeloid cells with phenotype similar to MO-DCs (CD11c^+^CD11b^+^F4/80^+^DCsign^+^) that express high levels of TNF-α and iNOS, similar to Tip-DCs \[[@R29]\]. The requirement of CCR4 in this model was unexpected, since most studies indicate a role of CCR4 in Th2-mediated immune responses. We hypothesize that during *PbN* infection, CCR4 mediates migration of MO-DCs to the lungs, where they differentiate into Tip-DC in a CD8^+^ T cell- and IFN-γ dependent manner. Finally, our results suggest that Tip-DC are the main effector cells and NOS2 a key metabolic enzyme that mediates tissue damage and development of MA-ARDS/ALI.

Importantly, our results show that while CCR4 play a key role, CCR2 deficiency does not impact on MA-ARDS/ALI development. Different from CCR4, β2m, IFN-γ and NOS2 deficient mice, CCR2^−/−^ mice showed lung damage and lethality similar to WT mice. Importantly, parasitemia and parasite load in the lungs in the various knockout, including the CCR4^−/−^ mice, and WT mice did not correlate with development of MA-ARDS/ALI. Hence, we assume that the main cause of MA-ARDS/ALI is the inflammation induced by *PbN* infection, rather than direct tissue damage caused directly by the parasite.

CCR2 has been implicated in monocyte egress from bone marrow and distribution to lymphoid organs. Indeed, we found that the frequence and number of monocytes was lower, both in blood and spleen of control and infected CCR2^−/−^. Intriguingly, the lower number of monocytes in peripheral lymphoid organ did not impact in the development of tissue lung damage. While monocyte migration to the lungs of CCR2^−/−^ mice was delayed, at 9 days post-infection the frequence and number of MO-DCs in the lungs were similar to that found in WT mice. We also found an increased numbers of neutrophils in the lung from infected CCR2^−/−^ mice, which may contribute to lung tissue damage and lethality. Our results with CCR2^−/−^ mice are somewhat consistent with data obtained from another model (*P. berghei* ANKA) of MA-ARDS/ALI. Similar to our results at day 5 and 7 post-infection, they found an impaired migration of inflammatory monocytes on day 6 post-infection. In addition, CCR2−/− were still highly susceptible to MA-ARDS/ALI, contrasting with CD36^−/−^ that were highly resistent \[[@R37]\].

In sharp contrast with CCR2−/− mice infected with *PbN*, the frequence of monocytes in the blood and spleen of CCR4^−/−^ was similar to WT mice, whereas the migration of MO-DCs was severily impaired in all time points. Hence, we conclude that while CCR2 contributes to monocyte egress from bone marrow and homing of these cells in peripheral lymphoid organs, it is the CCR4 that mediate the migration of monocytic cells to the lungs of *PbN* infected mice.

Importantly, CCR4 was shown to influence macrophages and Th2 lymphocytes recruitment and the development of pulmonary fibrosis \[[@R38]\]. However, we found that expression of CCL17 and CCL22 was very low in the lungs of *PbN* infected mice. Nevertheless, we observed that expression of CCL2 and CCL3 mRNA are enhanced in the lungs of *PbN*-infected mice. CCL2 chemokine was previously described to mediate T cell migration in a CCR4-dependent manner \[[@R39], [@R40]\]. Consistently, the first study that described the CCR4^−/−^ mice, it was observed that in a LPS-induced septic shock, macrophage migration to the peritoneal site was partially dependent on CCR4. This same work showed that splenocytes and thymocytes isolated from the CCR4^−/−^ mice failed to respond to the CCL3 \[[@R41]\]. In addition, in a Th1/Th17-mediated experimental autoimmune encephalomyelitis model (EAE), GMCSF/IL-23 producing dendritic cells are activated via CCR4 \[[@R42]\]. Hence, our results suggests that other CCR4 ligands different from CCL17 and CCL22 are acting on leukocyte recruitment during Th1 and CD8^+^ T cells mediated inflammation, and this needs to be further investigated.

The importance of CD8^+^ T cells in MA-ARDS/ALI was studied before, but the mechanisms by which these cells mediate lung tissue damage have not been defined \[[@R17]\]. We confirmed that both CD8 and IFN-γ deficient mice are resistant to MA- ARDS/ALI induced by *PbN*. However, the migration of CD8^+^ T cells to the lungs was not affected in the CCR4^−/−^ mice infected with *PbN*. Hence, our results indicate that in this model, CD8^+^ T cells play an indirect role in lung tissue damage. In addition, we found that IFN-γ, but not CD8^+^ T cells, was essential for the presence of mature MO-DCs (CD11b^+^Ly6c^+^CD11c^+^DCsign^+^) in the lungs of *PbN* infected mice.

It is known that mice deficient in NOS2 are resistant to bleomycin-induced lung injury \[[@R43]\]. Importantly, we found that *PbN*-infected β2-microglobulin^−/−^ mice have reduced number of Tip-DC, when compared to C57BL/6 mice. Furthermore, *PbN*-infected NOS2^−/−^ mice were shown to be resistant to MA-ARDS/ALI and TNFα seems no to be involved on NOS2 mediated lung injury, since F4/80^+^CD11b^+^Ly6c^+^ cells from TNFR1^−/−^ mice expressin normal levels of NOS2 when compare to infected WT mice. In contrast, Tip-DCs do not differentiate in IFNγ mice, which are resistant to MA-ARDS/ALI. Importantly, we found that over 94% of IFNγ^+^ cells in the lungs and more than 98% of IFN-γ^+^ cells in the spleen are CD3^+^ T cells.

Our results are distinct from those obtained with another mouse model of MA-ARDS/ALI using DBA-2 mice infected with *PbA*. In this model, neutrophil extracellular traps (NETs), myeloperoxidase and reactive oxygen species are the main mediators of lung damage \[[@R44]\]. However, lung injury in malaria patients is associated with high frequence of monocytes, macrophages and lymphocytes, whereas neutrophils are less frequent cells \[[@R45]\]. Furthermore, consistent with Tip-DC phenotype, TNF-α production is associated with NOS2 expression in *P. falciparum* malaria patients \[[@R46]\]. In addition, a single nucleotide polymorphism on *NOS2* appears to influence the development of severe malaria \[[@R47]\].

Importantly, targeting CCR4 has been used as important therapeutic intervention in different experimental models of Th2-meadiate pathology and cancer cells. For instance, the use of a CCR4 antagonist effectively attenuated allergic lung inflammation in mice \[[@R48]\]. In a renal cancer model, the use of CCR4 antagonist resulted in a reduced immature myeloid cell infiltrate and increased numbers of NK cells \[[@R49]\]. Furthermore, CCR4 is expressed in hepathocellular carcinoma in humans and has been proposed as therapeutic target \[[@R50]\].

In conclusion, our results highlight the importance of CCR4 on migration of MO-DCs in MA-ARDS/ALI, which is mediated by Type 1 immune responses. Our data suggest that the CCR4 ligands CCL2 and CCL3, but not CCL17 and CCL22, play the key role in the MO-DC recruitment to the lung of *PbN*-infected mice. In addition, we speculate that IFN-γ locally produced by CD8^+^ T cells induces the final differentiation of MO-DC to TipDC, which in turn mediate tissue pathology by producing high levels of reactive nitrogen species. Finally, MA-ARDS/ALI seems to be inflammatory disease induced by sequestration of infected erythrocytes. If our findings are validated in humans undergoing acute episode of malaria, they provide a new insight for therapeutic intervention of MA-ARDS/ALI.
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![CCR4 expression on hematopoietic cells is necessary for MA-ARDS/ALI development.\
**(A)** Hemorrhagy (left quadrants) and permeability by evans blue dye (right quadrants) from lungs of uninfected controls (top quadrants) and C57BL/6 and CCR4^−/−^ mice 9 days post-infection (bottom quadrants). The bar graph indicates the quantification of evans blue infiltrated in the lungs. **(B)** Weights of lungs from WT and CCR4 knockout mice were determined at 9 days post-infection. **(C)** Histopathology scores, based on edema and inflammatory infiltrate were evaluated after H&E staining. **(D)** Parasitemia of C57BL/6 and CCR4^−/−^ mice. **(E)** Survival of *PbN*-infected C57BL6 and CCR4^−/−^ mice. **(F)** WT chimera mice reconstituted with bone marrow cells from CCR4^−/−^ or WT control (CCR4^+/+^) mice. **(G)** CCR4^−/−^ chimera mice reconstituted with bone marrows from WT or CCR4^−/−^ mice. Data are representative of at least two independent experiments (n = 4--6 mice per group).](nihms-1507053-f0001){#F1}

![MA-ARDS/ALI is primarily associated with CXCR3^+^ and Tbet^+^ T cells.\
**(A)** Expression of CCR4 (left panels) and CXCR3 (right panels) on CD4^+^ T cells (top panels) or CD8^+^ T cells (bottom panels) from uninfected and *Pb*N-infected C57BL/6 mice. Graphs indicating MFI of the CCR4 and CXCR3 expression by CD8+ and CD4+ are shown in the right. **(B)** Total number of CD8^+^ (top panel) and CD4^+^ (bottom panel) T cells in the lungs of WT and CCR4^−/−^ mice infected with *Pb*N. **(C)** Intracellular staining of the transcription factors Tbet, GATA-3, RORγ and FoxP3 in CD4^+^ T cells from uninfected controls (top panels) or *Pb*N-infected (bottom panels) WT (left panels) and CCR4^−/−^ mice (right panels). **(D)** Total number of Tbet^+^ (left top), GATA-3^+^ (right top), RORγt^+^ and FoxP3^+^ (right bottom) CD4^+^ T and CD8^+^ T cells in the lungs of uninfected controls (white bars) and *Pb*N-infected (black bars) WT and CCR44C4 mice. Data **(A--D)** are representative of at least two independent experiments (n = 4--6 mice per group).](nihms-1507053-f0002){#F2}

![Emergence of TNF-α and iNOS producing dendritic cells (Tip-DC) in the lungs from *Pb*N infected mice.\
(A) Dot plots indicating kinetics of F4/80^+^CD11b^+^Ly6c^+^ cells in the lungs of *Pb*N-infected WT mice. **(B)** Characterization of the F4/80^+^CD11b^+^Ly6c^+^ cells from uninfected and infected WT mice at 9 days post-infection by flow cytometry shows that they are CD68^−^CD115^−^CD135^−^ DCsign^+^CD11c^+^CD80 ^+^CD86^+^MHCII^+^. **(C)** Intracellular staining of TNF**α** and NOS2 expression by MO-DC harvested from lungs of *PbN*-infected C57BL/6 mice at 9 days post infection. Dot plots with frequency (left) and graph with total number (right) of Tip-DCs, alveolar macrophages (Alveolar MO) and neutrophils. Data **(A--C)** are representative of at least two independent experiments (n = 4--6 mice per group).](nihms-1507053-f0003){#F3}

![Emergence of Tip-DCs in the lungs of *Pb*N-infected mice is mediated by CCR4.\
**(A)** Expression of CCR4 ligands in the lungs of uninfected and *Pb*N-infected WT mice was evaluated by qPCR. **(B)** Quantification of CCL2 by ELISA from homogenate originated from lungs of C57BL/6 mice. **(C)** Histogram showing CCR2 and CCR4 expression by monocyte-derived cells (F4/80 ^+^CD11b^+^) harvested from uninfected and infected C57BL/6 mice (top panel). Graphs indicating MFI of the CCR2 and CCR4 expression by F4/80 ^+^CD11b^+^ that refers to the representative histograms (top panel). **(D)** Dot plots showing the frequence of F4/80 ^+^CD11b^+^Ly6c^−^ and F4/80 ^+^CD11b^+^Ly6c^+^ monocytes in the lungs of control and *PbN*-infected WT, CCR2^−/−^ and CCR4^−/−^ mice. **(E)** Total number of F4/80 ^+^CD11b^+^Ly6c^+^ cells found in the lungs of uninfected controls and *Pb*N-infected WT, CCR2^−/−^ and CCR4^−/−^ mice **(F)** Survival curve of CCR2^−/−,^ CCR4^−/−^ and WT mice after challenge with *Pb*N. Data **(A--E)** are representative of at least two independent experiments (n = 4--6 mice per group).](nihms-1507053-f0004){#F4}

![CD8^+^ T cells and endogenous IFN-γ are necessary for monocyte derived dendritic cells differentiation and activation as well as lung damage.\
**(A)** MA-ARDS/ALI-induced hemorrhage is attenuated in the lungs of *PbN*-infected β2-microglobulin^−/−^ and IFN-γ^−/−^ mice, compared to WT mice. **(B)** Delayed mortality in *Pb*N-infected WT, β2-microglobulin^−/−^ and IFN-γ^−/−^ mice. **(C)** Expression of CXCL9 and CXCL10 mRNA in the lungs of uninfected and *Pb*N-infected WT, β2-microglobulin^−/−^ and IFN-γ^−/−^ mice. **(D)** Histogram illustrating the expression of DCsign (left panel) and CD11c (right panel) in F4/80^+^CD11b^+^Ly6c^+^ cells in the lungs from control (uninfected) and *Pb*N-infected WT, β2-microglobulin^−/−^ and IFN-γ^−/−^ mice (E) MFI bar graphs relative to the histograms of DCsign and CD11c shown in painel D. **(F)** ELISA quantification of IFN-γ and TNF-α levels in lung homogenates from control and *Pb*N-infected WT mice. **(F)** Number of IFN-γ producing CD4^+^ T and CD8^+^ T cells from lungs of control and *Pb*N-infected C57BL/6 mice. **(G)** Numbers of CD11b^+^Ly6c^+^ TNFα^+^NOS2^+^ cells (Tip-DCs) from WT and β2-microglobulin^−/−^ mice. Data **(A--G)** are representative of two independent experiments (n = 4--5 mice per group).](nihms-1507053-f0005){#F5}

![NOS2^−/−^ mice are resistant to *Pb*N-induced MA-ARDS/ALI.\
**(A)** Lungs from uninfected (top quadrants) and *Pb*N-infected (bottom quadrants) WT and NOS2^−/−^ mice. **(B)** Survival curves of WT and NOS2^−/−^ mice infected with *Pb*N. **(C)** Dot plot showing the frequence of F4/80^+^CD11b^+^Ly6c^+^ cells in WT and NOS2^−/−^ mice. Histogram showing the DCsign expression (right, top panel) and MFI graph (right, bottom panel) of F4/80^+^CD11b^+^Ly6c^+^ cells from lungs of control and *Pb*N-infected WT and NOS2^−/−^ mice. **(D)** Gate strategy (dot plots) to quantify the frequence of NOS2^+^ expressing cells. Graph indicates the frequence of Tip-DCs (F4/80^+^CD11b^+^CD11c^+^TNF-α^+^NOS2^+^) compared to non-Tip-DC leukocyte populations that express NOS2 in the lungs of WT infected mice. Data **(A--D)** are representative of two independent experiments (n = 4--5 mice per group).](nihms-1507053-f0006){#F6}
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